trending Market Intelligence /marketintelligence/en/news-insights/trending/_gIq0xcxrRZHRk0P57je1g2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Medtronic gets FDA approval for cardiac mapping system

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Medtronic gets FDA approval for cardiac mapping system

Medtronic plc received 510(k) clearance from the U.S. FDA for its noninvasive cardiac mapping system.

The company will employ a strategic rollout of the technology in the geographies where it is cleared.

The CardioInsight noninvasive 3D mapping system is used for mapping of irregular heart rhythms in the upper and lower chambers of the heart. It also provides electroanatomic 3D maps of the heart.